[

covaxin

]
PAGE 3

WHO's nod for Covaxin delayed again over technical queries: Reports

Covaxin manufacturer Bharat Biotech has said it has submitted all data required for clearance of the Covid-19 vaccine. 
Empty Covaxin vaccine vials are after theCovid-19 vaccination in Thane, (Praful Gangurde/HT File Photo)
Empty Covaxin vaccine vials are after theCovid-19 vaccination in Thane, (Praful Gangurde/HT File Photo)
Published on Sep 28, 2021 06:19 AM IST
Copy Link
Byhindustantimes.com | Written by Meenakshi Ray, New Delhi

Court seeks Centre’s stand on cancer patient’s plea to take Covaxin as 2nd dose

The petitioner stated in his plea that he developed a severe reaction and was hospitalised for four days after receiving Covishield as the first dose of Covid-19 vaccine, and that he wants to take Covaxin as the second dose as per his doctor’s advice. 
Mixing one dose each of Covaxin and Covishield vaccine against Covid-19 has not received any official nod from the central government yet.
Mixing one dose each of Covaxin and Covishield vaccine against Covid-19 has not received any official nod from the central government yet.
Updated on Sep 27, 2021 05:42 PM IST
Copy Link
Written by Sharangee Dutta | Edited by Avik Roy, Hindustan Times, New Delhi

Bharat Biotech completes phase 2/3 trials of Covaxin in children

“Paediatric Covaxin just completed phase 2/3 trials. The data analysis is going on. We will be submitting the data by next week,” Bharat Biotech’s chairman and managing director Krishna Ella said.
Briefing on the production of Covaxin, Krishna Ella said that it would reach 55 million doses in October.(AP)
Briefing on the production of Covaxin, Krishna Ella said that it would reach 55 million doses in October.(AP)
Published on Sep 21, 2021 04:19 PM IST
Copy Link
Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi

Covaxin's wait continues, WHO ‘delays’ emergency use nod till October 5

Bharat Biotech said on Friday that it has submitted all the data to WHO for emergency use listing (EUL) of Covaxin and is now awaiting feedback.
Bharat Biotech's Covaxin, India's first indigenous Covid-19 vaccine. (File Photo / AFP)
Bharat Biotech's Covaxin, India's first indigenous Covid-19 vaccine. (File Photo / AFP)
Published on Sep 18, 2021 07:43 AM IST
Copy Link
Written by Joydeep Bose | Edited by Meenakshi Ray, Hindustan Times, New Delhi

Inappropriate to comment on WHO's Covaxin approval process: Bharat Biotech

  • Bharat Biotech said it has responded to all clarifications sought by the WHO following the submission of Covaxin’s clinical trial data for Emergency use Listing in early July.
The Phase 3 clinical trials data of Covaxin demonstrated 77.8 per cent efficacy.(Bloomberg)
The Phase 3 clinical trials data of Covaxin demonstrated 77.8 per cent efficacy.(Bloomberg)
Published on Sep 17, 2021 03:59 PM IST
Copy Link
Byhindustantimes.com | Written by Kunal Gaurav, Hindustan Times, New Delhi

'Need more scientific data to clarify’: Centre on mixing of Covid-19 vaccines

The Drugs Controller General of India in August approved a proposal by the CMC Vellore, Tamil Nadu, to conduct a study to analyse the mixing of one dose each of Covaxin and Covishield doses.
The study on mixing of Covid-19 vaccines is being conducted with 300 volunteers who are administered a dose each of Covaxin and Covishield – the first two vaccines to receive the DCGI nod.
The study on mixing of Covid-19 vaccines is being conducted with 300 volunteers who are administered a dose each of Covaxin and Covishield – the first two vaccines to receive the DCGI nod.
Published on Sep 14, 2021 09:51 PM IST
Copy Link
Written by Sharangee Dutta | Edited by Avik Roy, Hindustan Times, New Delhi

WHO approval for Bharat Biotech’s Covaxin likely this week: Report

  • After receiving Bharat Biotech’s documentation WHO chief scientist Dr Soumya Swaminathan had said on July 9 that the final approval will be granted in four to six weeks.
Covaxin was found to be nearly 77.8% effective against symptomatic Covid-19 cases in final phase 3 trials, according to Bharat Biotech. (AP Photo/Bikas Das)(AP)
Covaxin was found to be nearly 77.8% effective against symptomatic Covid-19 cases in final phase 3 trials, according to Bharat Biotech. (AP Photo/Bikas Das)(AP)
Published on Sep 13, 2021 05:25 PM IST
Copy Link
Byhindustantimes.com, Hindustan Times, New Delhi

How to identify fake Covid-19 vaccines? Centre issues guidelines

Covid-19 vaccines being used in the country's vaccination drive include the Serum Institute of India's Covishield, Bharat Biotech's Covaxin and the Russian vaccine Sputnik V.
As many as 684.6 million vaccine doses have been administered so far in the country. (File Photo)
As many as 684.6 million vaccine doses have been administered so far in the country. (File Photo)
Published on Sep 05, 2021 02:28 PM IST
Copy Link
Byhindustantimes.com | Written by Meenakshi Ray, New Delhi

Mansukh Mandaviya rolls out Gujarat facility’s first Covaxin batch

The Chiron Behring Vaccines plant, a wholly-owned subsidiary of Bharat Biotech at Ankleshwar, has a production capacity of at least 10 million doses per month
Union health minister Mansukh Mandaviya releases the first commercial batch of Covaxin, at Ankaleshwar on Sunday. ANI
Union health minister Mansukh Mandaviya releases the first commercial batch of Covaxin, at Ankaleshwar on Sunday. ANI
Updated on Aug 29, 2021 11:49 PM IST
Copy Link
ByRhythma Kaul, New Delhi

News updates from HT: AIIMS doctor weighs in on schools reopening in Delhi

Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
Representational image(PTI)
Representational image(PTI)
Updated on Aug 28, 2021 05:10 PM IST
Copy Link
Byhindustantimes.com, New Delhi

Have you got one dose of Covaxin? ICMR study reveals how protected you are

If you have been infected before, then the response of one Covaxin shot is similar to that of two in persons never infected by Covid, the study said.
Taking both doses of any vaccine -- Covaxin, Covishield, Sputnik V-- is mandatory for the maximum protection against Covid-19.(AFP)
Taking both doses of any vaccine -- Covaxin, Covishield, Sputnik V-- is mandatory for the maximum protection against Covid-19.(AFP)
Published on Aug 28, 2021 03:48 PM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

News updates from HT: Pfizer's Covid-19 vaccine receives full approval from FDA

Here are today’s top news, analysis, and opinion at 9pm. Know all about the latest news and other news updates from Hindustan Times.
Pfizer's Covid-19 vaccine (Reuters)
Pfizer's Covid-19 vaccine (Reuters)
Published on Aug 23, 2021 08:56 PM IST
Copy Link
Byhindustantimes.com, New Delhi, Hindustan Times

Digital vaccination certificates for Covishield, Covaxin trial participants

11,349 trial participants have been issued their certificates through Co-WIN, the Union health ministry noted in a statement.
A health worker inoculates a beneficiary against Covid-19 at a vaccination camp organised in Mumbai. (HT PHOTO/Used only for representation)
A health worker inoculates a beneficiary against Covid-19 at a vaccination camp organised in Mumbai. (HT PHOTO/Used only for representation)
Published on Aug 23, 2021 07:11 PM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral, New Delhi

Covid booster dose will definitely be recommended, says ICMR-NIV director

Serum Institute of India chairman Cyrus Poonawalla recently said that he has taken a booster shot of Covishield and around 7,000-8,000 employees of Serum Institute have been given booster doses.
Booster dose will definitely be recommended in India in future, Dr Priya Abraham has said.(PTI)
Booster dose will definitely be recommended in India in future, Dr Priya Abraham has said.(PTI)
Published on Aug 19, 2021 10:00 AM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Fully vaccinated person cannot be re-vaccinated, Centre tells Kerala HC

  • The court was hearing a petition by an expat, who had received two doses of Covaxin, but wanted to be revaccinated with Covishield now, as Covaxin was not approved in Saudi Arabia where he had his job.
The central government told the court that a person who receives
The central government told the court that a person who receives "more than two vaccines is more likely to have health problems." (PTI Photo)
Published on Aug 17, 2021 09:02 PM IST
Copy Link
ANI | | Posted by Sharangee Dutta, Hindustan Times, New Delhi

What if Covishield and Covaxin mix fails? Cyrus Poonawalla presents 2 scenarios

Both the companies can blame each other for the failure, Cyrus Poonawalla said explaining why he is not in favour of Covid vaccine cocktail. 
The efficacy of the approach in mixing vaccines is not proved, Cyrus Poonawalla said. 
The efficacy of the approach in mixing vaccines is not proved, Cyrus Poonawalla said. 
Published on Aug 13, 2021 08:22 PM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Health minister meets WHO chief scientist, talks nod for Covaxin

Hyderabad-based Bharat Biotech has applied for WHO’s emergency use listing for the anti Covid-19 vaccine, Covaxin, that the company co-developed with the Indian Council of Medical Research (ICMR).
A nurse prepares a dose of Bharat Biotech Ltd. Covaxin vaccine at a Covid-19 vaccination center.(Bloomberg)
A nurse prepares a dose of Bharat Biotech Ltd. Covaxin vaccine at a Covid-19 vaccination center.(Bloomberg)
Updated on Aug 13, 2021 06:08 AM IST
Copy Link
ByHT Correspondent, New Delhi

Covaxin 65% efficient against Delta variant, 75 million doses supplied so far

“Supplied 75 million doses of Covaxin, more to be supplied in August. Our vaccine has 65% efficacy against Delta," said Suchitra Ella, Bharat Biotech's joint managing director.
Bharat Biotech committed last month to supply 500 million doses of Covaxin to the Union government.(Representational image)
Bharat Biotech committed last month to supply 500 million doses of Covaxin to the Union government.(Representational image)
Published on Aug 12, 2021 11:16 PM IST
Copy Link
Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi

DCGI accepts proposal to study mixing of Covid-19 vaccine doses

The research will analyse mixing a dose each of Covaxin and Covishield. It will be conducted at Christian Medical College in Tamil Nadu's Vellore.
Representative Image
Representative Image
Published on Aug 11, 2021 08:00 AM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral, New Delhi

Need for Covid booster dose in India under close watch, says Govt

Covid booster shot and whether India will need a third dose of vaccine against Covid is under the watch of the experts, Dr VK Paul said.
Expert committee has already discussed Covid booster dose and its necessity in India.
Expert committee has already discussed Covid booster dose and its necessity in India.
Published on Aug 10, 2021 07:34 PM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Govt approves Covaxin manufacturing facility in Gujarat’s Ankleshwar

  • Bharat Biotech had said in a press statement that IIL’s Ankleshwar-based production facility will add another 200 million doses to its overall vaccine production.
The Ankleshwar based manufacturing facility is expected to roll out Covaxin doses from the fourth quarter of the year. (Praful Gangurde / HT Photo)(HT PHOTO)
The Ankleshwar based manufacturing facility is expected to roll out Covaxin doses from the fourth quarter of the year. (Praful Gangurde / HT Photo)(HT PHOTO)
Published on Aug 10, 2021 01:14 PM IST
Copy Link
Byhindustantimes.com | Written by Ayshee Bhaduri | Edited by Amit Chaturvedi, Hindustan Times, New Delhi

Mixing shots safe and effective: Study

While the findings could benefit the immunisation programme, there is a need for a randomised controlled trial to further corroborate the findings.
According to the study, none of the participants enrolled in the study had any serious adverse event following immunisation (AEFI) within 30 minutes of inoculation with the first or second dose.(AFP)
According to the study, none of the participants enrolled in the study had any serious adverse event following immunisation (AEFI) within 30 minutes of inoculation with the first or second dose.(AFP)
Updated on Aug 09, 2021 05:09 AM IST
Copy Link
ByRhythma Kaul, Hindustan Times, New Delhi

Covishield, Covaxin mix can give better results, says ICMR

The study was conducted on 18 people who have received two doses of two different vaccines and it has not yet been peer-reviewed, reports said.
Mix of Covishield and Covaxin has now been found to be more effective than both doses of the same vaccine, reports said. (PTI)
Mix of Covishield and Covaxin has now been found to be more effective than both doses of the same vaccine, reports said. (PTI)
Published on Aug 08, 2021 01:02 PM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Covaxin and Covishield against Delta, Delta Plus: What recent studies revealed

This week, ICMR has revealed the findings of its real-life studies on the effectiveness of Covishield and Covaxin against the Delta variant of SARs-CoV-2.
ICMR studies published this week have revealed that both Covaxin and Covishield are effective against the Delta variant. (PTI)
ICMR studies published this week have revealed that both Covaxin and Covishield are effective against the Delta variant. (PTI)
Published on Aug 08, 2021 06:17 AM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Covid-19: Ocugen says Covaxin under 'active review' in Canada

In July, Bharat Biotech's partner for US and Canada markets completed submission of papers for emergency use authorisation of the vaccine in Canada.
Bharat Biotech's Covaxin (HT File Photo)
Bharat Biotech's Covaxin (HT File Photo)
Published on Aug 07, 2021 03:03 PM IST
Copy Link
Byhindustantimes.com | Written by Karan Manral, New Delhi

'Over 200 tests for every batch': Bharat Biotech on Covaxin quality concern

There has been no compromise in vaccine quality and Bharat Biotech has not even sought indemnity from the government for any adverse effect from Covaxin, the vaccine manufacturer said.
Bharat Biotech on Thursday issued a statement asserting that there is no quality concern regarding Covaxin. (AFP)
Bharat Biotech on Thursday issued a statement asserting that there is no quality concern regarding Covaxin. (AFP)
Published on Aug 05, 2021 08:05 PM IST
Copy Link
Byhindustantimes.com | Written by Poulomi Ghosh

Indian expat files plea to Kerala HC to get re-vaccinated with Covishield

  • The petitioner has already been fully vaccinated with both doses of the Bharat Biotech manufactured, India’s first indigenous Covid-19 vaccine ‘Covaxin’.
The plea comes as India’s indigenous vaccine Covaxin is yet to be recognised in Saudi Arabia. (Praful Gangurde / HT Photo)
The plea comes as India’s indigenous vaccine Covaxin is yet to be recognised in Saudi Arabia. (Praful Gangurde / HT Photo)
Published on Aug 05, 2021 04:44 PM IST
Copy Link
Written by Sharangee Dutta | Edited by Poulomi Ghosh, Hindustan Times, New Delhi

Covaxin effectively neutralises Delta Plus variant of Covid-19: New ICMR Study

'Covaxin effectively neutralises Delta Plus variant'
'Covaxin effectively neutralises Delta Plus variant'
Published on Aug 03, 2021 07:13 PM IST
Copy Link

Covishield output to be increased to 120 million, Covaxin to 58 million: Govt

The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will help meet the domestic demand, Union health minister Mansukh Mandaviya said.
Union health minister Mansukh Mandaviya said that India has administered 470 million doses of Covid-19 vaccine so far.(HT File Photo)
Union health minister Mansukh Mandaviya said that India has administered 470 million doses of Covid-19 vaccine so far.(HT File Photo)
Published on Aug 03, 2021 05:33 PM IST
Copy Link
Byhindustantimes.com | Written by Amit Chaturvedi, Hindustan Times, New Delhi

News updates from HT: J&K Police release list of 'top 10' active terrorists

  • Here are today’s top news, analysis and opinion at 5pm. Know all about the latest news and other news updates from Hindustan Times.
Know all about the latest news and other news updates from Hindustan Times.(PTI)
Know all about the latest news and other news updates from Hindustan Times.(PTI)
Published on Aug 03, 2021 04:56 PM IST
Copy Link
Byhindustantimes.com, Hindustan Times, New Delhi
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, December 06, 2021